TIGIT and neoplasm: It is proposed that TIGIT may take part in tumor progression in some solid tumors and hematologic malignancies, including refractory multiple myeloma, metastatic NSCLC, esophageal cancer, cervical cancer, and melanoma [19, 22, 70].